Biophytis announces its participation to a Virtual Workshop the development of Function promoting therapies for the elderly, organized by the National Institute on Aging based in Baltimore, USA.
Dr Waly Dioh, Chief Clinical Operations Officer of Biophytis, will present the progress of its drug candidate and will meet with public and private players as well as regulatory body representatives in the field of mobility for the elderly, all potential partners in the context of the upcoming start of Sarconeos (BIO 101) phase III in sarcopenia.
The Workshop, named “Development of function promoting therapies: public health need, molecular targets, and drug development” will be held online from the 20th to the 22nd of March, 2022. This conference is organized by the National Institute on Aging (NIA), a branch of the National Institutes of Health (NIH), based in the United States.
Headquartered in Baltimore, Maryland, NIA is coordinating a broad scientific effort to understand the nature of aging and enable elderly people to live a healthy and active life.